AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 69 filers reported holding AKERO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,510,617 | +5.8% | 1,769,684 | -2.3% | 4.26% | +31.2% |
| Q2 2023 | $84,586,966 | +8.1% | 1,811,672 | -11.4% | 3.25% | -4.3% |
| Q1 2023 | $78,218,323 | -45.8% | 2,044,389 | -22.4% | 3.39% | -42.5% |
| Q4 2022 | $144,283,578 | +166.3% | 2,632,912 | +65.5% | 5.90% | +180.9% |
| Q3 2022 | $54,176,000 | +261.2% | 1,591,085 | +0.2% | 2.10% | +266.7% |
| Q2 2022 | $15,000,000 | -34.0% | 1,587,285 | -0.9% | 0.57% | -19.3% |
| Q1 2022 | $22,736,000 | -32.9% | 1,602,285 | 0.0% | 0.71% | -7.8% |
| Q4 2021 | $33,888,000 | -43.6% | 1,602,285 | -40.4% | 0.77% | -26.5% |
| Q3 2021 | $60,064,000 | -13.7% | 2,687,444 | -4.2% | 1.05% | +1.7% |
| Q2 2021 | $69,591,000 | -4.6% | 2,804,944 | +11.6% | 1.03% | +0.3% |
| Q1 2021 | $72,924,000 | +21.7% | 2,513,746 | +8.2% | 1.03% | +41.5% |
| Q4 2020 | $59,922,000 | -16.7% | 2,322,557 | -0.6% | 0.73% | -45.0% |
| Q3 2020 | $71,936,000 | +636.1% | 2,336,357 | +495.8% | 1.32% | +633.9% |
| Q2 2020 | $9,772,000 | -19.1% | 392,152 | -31.1% | 0.18% | -46.7% |
| Q1 2020 | $12,074,000 | -53.3% | 569,513 | -51.1% | 0.34% | -45.3% |
| Q4 2019 | $25,835,000 | -2.5% | 1,164,002 | -0.0% | 0.62% | -30.2% |
| Q3 2019 | $26,490,000 | +18.3% | 1,164,402 | -0.4% | 0.89% | +40.0% |
| Q2 2019 | $22,383,000 | – | 1,168,802 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |